Ingevity Corporation (NYSE:NGVT – Get Free Report) CEO David Li sold 5,000 shares of the company’s stock in a transaction dated Friday, August 14th. The shares were sold at an average price of $75.73, for a total value of $378,650.00. Following the transaction, the chief executive officer directly owned 125,636 shares in the company, valued at $9,514,414.28. This represents a 3.83% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Ingevity Stock Down 2.4%
Ingevity stock traded down $1.78 during midday trading on Tuesday, reaching $74.01. The company’s stock had a trading volume of 177,777 shares, compared to its average volume of 291,037. The company has a debt-to-equity ratio of 22.52, a current ratio of 1.61 and a quick ratio of 1.15. The stock has a market capitalization of $2.54 billion, a P/E ratio of 50.34 and a beta of 1.16. The stock’s 50-day simple moving average is $73.75 and its 200-day simple moving average is $71.72. Ingevity Corporation has a 52-week low of $45.85 and a 52-week high of $79.29.
Ingevity (NYSE:NGVT – Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The company reported $1.74 earnings per share for the quarter, topping analysts’ consensus estimates of $1.33 by $0.41. Ingevity had a return on equity of 284.70% and a net margin of 4.65%.The business had revenue of $314.10 million for the quarter, compared to analyst estimates of $312.20 million. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. On average, sell-side analysts expect that Ingevity Corporation will post 5.4 EPS for the current year.
Wall Street Analysts Forecast Growth
View Our Latest Report on NGVT
Institutional Investors Weigh In On Ingevity
A number of institutional investors and hedge funds have recently modified their holdings of NGVT. Global Retirement Partners LLC purchased a new stake in Ingevity in the fourth quarter valued at approximately $27,000. Meeder Asset Management Inc. purchased a new position in Ingevity during the 4th quarter worth approximately $33,000. Geneos Wealth Management Inc. lifted its stake in Ingevity by 85.8% during the 2nd quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock valued at $36,000 after acquiring an additional 387 shares during the period. Frazier Financial Advisors LLC acquired a new stake in Ingevity during the 2nd quarter valued at approximately $37,000. Finally, Headlands Technologies LLC purchased a new stake in shares of Ingevity in the 2nd quarter valued at $46,000. Institutional investors and hedge funds own 91.59% of the company’s stock.
About Ingevity
Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.
The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.
Further Reading
- Five stocks we like better than Ingevity
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.
